What is kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Kidney Disease

Kidney disease is defined as abnormalities in kidney structure or function that have implications for health, and includes both acute and chronic conditions with varying degrees of severity based on glomerular filtration rate (GFR) and evidence of kidney damage. 1

Types of Kidney Disease

Acute Kidney Diseases and Disorders (AKD)

  • Definition: Abnormalities in kidney structure or function present for ≤3 months 1
  • Includes:
    • Acute Kidney Injury (AKI): Sudden decrease in kidney function manifested by:
      • Increase in serum creatinine within 48 hours to 7 days
      • Oliguria (reduced urine output)
    • AKD without AKI: Disorders with markers of kidney damage (hematuria, pyuria, urinary tract obstruction) without rapid GFR decline 1
  • Staging of AKI:
    • Stage 1: Mild
    • Stage 2: Moderate
    • Stage 3: Severe (may require dialysis, denoted as Stage 3D) 1

Chronic Kidney Disease (CKD)

  • Definition: Abnormalities in kidney structure or function present for >3 months 1, 2
  • Diagnostic Criteria:
    • GFR <60 mL/min/1.73 m² for >3 months, and/or
    • Evidence of kidney damage (proteinuria/albuminuria, abnormal urinary sediment, abnormal imaging) 2

Classification of CKD

GFR Categories (G1-G5)

Category GFR (mL/min/1.73 m²) Description
G1 ≥90 Normal or elevated
G2 60-89 Mildly decreased
G3a 45-59 Mildly to moderately decreased
G3b 30-44 Moderately to severely decreased
G4 15-29 Severely decreased
G5 <15 Kidney failure
[2]

Albuminuria Categories (A1-A3)

Category Albumin-to-Creatinine Ratio (mg/g) Description
A1 <30 Normal to mildly increased
A2 30-300 Moderately increased
A3 >300 Severely increased
[2]

Kidney Failure

Kidney failure (formerly called end-stage renal disease) is defined as:

  • GFR <15 mL/min/1.73 m² or treatment by dialysis 1
  • May be acute (≤3 months) or chronic (>3 months)
  • Can present with or without symptoms (uremic syndrome)

Treatment Options for Kidney Failure

  • Kidney Replacement Therapy (KRT):
    • Dialysis:
      • Hemodialysis (HD)
      • Peritoneal dialysis (PD)
    • Kidney transplantation:
      • Living donor (LDKT)
      • Deceased donor (DDKT) 1
  • Conservative care (for those not receiving KRT)

Causes of Kidney Disease

Kidney disease can result from various causes:

  • Diabetes - leading cause of CKD worldwide 3
  • Hypertension - second most common cause 3, 4
  • Glomerulonephritis - inflammation of the kidney's filtering units
  • Polycystic kidney disease - genetic disorder causing cysts in kidneys
  • Urinary tract obstruction
  • Medications (nephrotoxic drugs)
  • Autoimmune diseases (lupus, vasculitis)

Complications of Kidney Disease

As kidney function declines, various complications can develop:

  • Electrolyte imbalances - particularly potassium, sodium, calcium, and phosphate 5
  • Acid-base disorders - metabolic acidosis 5, 6
  • Anemia - due to decreased erythropoietin production 2
  • Bone disorders - mineral and bone disorder (MBD) 2
  • Cardiovascular disease - increased risk with declining kidney function 3
  • Hypertension - both a cause and consequence of kidney disease 7
  • Uremia - accumulation of waste products causing symptoms 1

Management by CKD Stage

Stage 1-2 (GFR ≥60 mL/min/1.73 m²)

  • Identify and treat underlying cause
  • Control blood pressure (target <130/80 mmHg) 2
  • Manage cardiovascular risk factors
  • Regular monitoring of kidney function

Stage 3 (GFR 30-59 mL/min/1.73 m²)

  • Continue above measures
  • Monitor for complications (anemia, bone disorders)
  • Medication dose adjustments
  • Avoid nephrotoxic medications

Stage 4 (GFR 15-29 mL/min/1.73 m²)

  • Manage complications actively
  • Prepare for kidney replacement therapy
  • Medication review and dose adjustments
  • Blood pressure management (target 130-139 mmHg systolic) 2

Stage 5 (GFR <15 mL/min/1.73 m²)

  • Implement kidney replacement therapy when indicated
  • Manage uremic symptoms
  • Consider transplant evaluation 2

Important Clinical Considerations

  • Terminology: The term "kidney" is preferred over "renal" when describing kidney disease and function 1
  • Medication adjustments: Many medications require dose adjustments based on GFR 2
  • Nephrotoxic medications: Avoid when possible, especially in advanced CKD 2
  • Contrast agents: Use caution with iodinated contrast in patients with kidney disease 1
  • Monitoring: Regular assessment of GFR, albuminuria, electrolytes, and acid-base status is essential 2

Prevention Strategies

  • Blood pressure control with ACE inhibitors or ARBs for those with albuminuria 2, 8
  • Glycemic control in diabetes
  • Dietary modifications (reduced dietary acid load) 6
  • Avoidance of nephrotoxic medications
  • Regular screening for those at high risk

Understanding kidney disease requires recognizing both acute and chronic conditions, their causes, and appropriate management strategies based on disease severity to improve outcomes and quality of life for affected individuals.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Kidney Disease (CKD) Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chronic Kidney Disease.

Revista da Associacao Medica Brasileira (1992), 2020

Research

Prevalence and socio-economic aspects of chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002

Research

Dietary Acid Load and Chronic Kidney Disease.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.